Login to Your Account



Cephalon's Parkinson's Study Stopped; No Benefit Showed

By Aaron Lorenzo


Friday, May 13, 2005
Cephalon Inc. called a halt to a late-stage study of a partnered Parkinson's disease drug, CEP-1347, as interim results revealed a lack of clinical benefit. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription